2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
2018 | | Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B | 김순선, 박래웅, 양민재, 정재연, 조성원, 조효정 |
2019 | | Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus | 김순선, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 정재연, 조효정, 황재철 |
2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정 |
2012 | | Interleukin-1ß and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infection | 김순선, 정재연, 조성원 |
2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
2004 | | Intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein thrombosis | 김재근, 김진홍, 왕희정, 원제환, 이기명, 정재연, 조성원, 함기백 |
2014 | | Is It Necessary for NAFLD Patients to be Screened for Hepatocellular Carcinoma? | 정재연 |
2021 | | Kit for diagnosing liver cancer comprising an agent capable of measuring expression level of miR-4661-5p | 김순선, 은정우, 정재연, 조효정 |
2021 | | Kit for diagnosing liver cancer comprising an agent capable of measuring expression level of serum exosomal long non-coding RNA | 김순선, 은정우, 정재연, 조효정 |
- | | Kit for diagnosis of early liver cancer | 김순선, 은정우, 정재연, 조효정 |
2005 | | Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. | 김진홍, 정재연, 조성원, 함기백 |
2015 | | Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis. | 정재연 |
2007 | | Liver Stiffness Measurement for the Diagnosis of Hepatic Fibrosis in Patients with Chronic Viral Hepatitis | 김영배, 정재연, 조성원 |
2018 | | Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance | 김순선, 정재연 |
2019 | | Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection | 정재연 |
2010 | | Loss of SM22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. | 김영배, 여말희, 이광재, 정재연, 조성원 |
2010 | | Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance. | 고경현, 이명희, 정재연, 조성원 |
2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
2008 | | Management of Chronic Hepatitis B in Treatment-Naive Patients | 정재연 |
2021 | | Method for diagnosing liver cancer by measuring expression level of miR-4661-5p | 김순선, 은정우, 정재연, 조효정 |
2021 | | Method for diagnosing liver cancer by measuring expression level of serum exosomal long non-coding RNA | 김순선, 은정우, 정재연, 조효정 |
- | | Method for providing information necessary for diagnosis of early liver cancer | 김순선, 은정우, 정재연, 조효정 |
2021 | | Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis | 김순선, 은정우, 정재연, 조효정 |
2021 | | microRNA biomarker derived exosome for diagnosis of early liver cancer and use thereof | 김순선, 은정우, 정재연, 조효정 |
2014 | | MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B | 정재연, 조성원 |
2005 | | MR findings in eosinophilic infiltration of the liver. | 김영배, 김재근, 선주성, 원제환, 이기명, 정재연 |
2013 | | Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population. | 정재연, 조성원 |
2013 | | Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy. | 김순선, 정재연, 조성원 |
2011 | | Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C | 김영배, 정재연, 조성원 |
2018 | | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects | 김순선, 김진홍, 양민재, 임선교, 정재연, 조성원, 조효정 |
2007 | | Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. | 정재연, 조성원 |
2013 | | Novel method of stent insertion for malignant lower rectal obstruction with proximal releasing delivery system (with video). | 김재근, 김진홍, 신성재, 유병무, 이기명, 임선교, 정재연, 황재철 |
- | | Peptide Therapeutic Agent of Autoimmune Diseases and Inflammatory Diseases | 김순선, 서창희, 정재연 |
2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
2013 | | Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. | 정재연, 조성원 |
2010 | | Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis | 김재근, 정재연, 조성원 |
2008 | | Problems faced by Korean patients with chronic liver disease and the role of the Korean Association for the Study of the Liver -Emphases on social discrimination, insufficiency of reimbursement coverage, and deficiency of the welfare system - | 정재연 |
2014 | | Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma. | 김순선, 안선주, 우현구, 정재연, 조성원, 조효정 |
2014 | | Prognostic significance of catalase expression and its regulatory effects on hepatitis B virus X protein (HBx) in HBV-related advanced hepatocellular carcinomas. | 왕희정, 이영수, 정재연, 조혜성 |
2021 | | Prognostic value of alpha-fetoprotein in patients who achieve a complete response to transarterial chemoembolization for hepatocellular carcinoma | 김순선, 정재연, 조효정 |
2008 | | Prospective Evaluation of Ultrathin Transnasal Esophagogastroduodenoscopy: Its Feasibility, Safety and Tolerance | 김진홍, 신성재, 유병무, 이광재, 이기명, 정성현, 정재연, 황재철 |
2004 | | Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. | 김진홍, 이광재, 이기명, 정재연, 함기백 |
2013 | | Radiofrequency ablation of metastatic liver masses: recurrence patterns and prognostic factors based on radiologic features. | 김재근, 김태희, 박미진, 이기명, 정재연 |
2007 | | RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. | 김진홍, 정재연, 조성원 |
2017 | | Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation | 정재연 |
2013 | | Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22. | 김경민, 김순선, 박선, 정재연, 조성원, 최용준 |
2015 | | Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. | 정재연, 조성원 |
2017 | | Response to Dr Giannini et al | 김순선, 정재연, 조성원, 조효정 |
2012 | | Revision and update on clinical practice guideline for liver cirrhosis | 김재근, 정재연, 조성원 |
2012 | | Risk factors for perforations associated with endoscopic submucosal dissection in gastric lesions: emphasis on perforation type | 김동훈, 김진홍, 신성재, 유병무, 유준환, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
2011 | | Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. | 김영배, 정재연, 조성원 |
2012 | | Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B | 김순선, 김영배, 정재연, 조성원 |
2014 | | Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B | 김순선, 김영배, 박주한, 안선주, 정재연, 조성원, 조효정 |
2010 | | Single nucleotide polymorphisms and the Linkage disequilibrium at the LDL receptor gene in Koreans | 정재연, 조성원 |
2010 | | Single nucleotide polymorphisms and the linkage disequilibrium at the LDL receptor gene in Koreans. | 정재연, 조성원 |
2008 | | Sorafenib in Advanced Hepatocellular Carcinoma | 정재연 |
2019 | | Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial | 정재연 |